Position in NVAX
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$337,631
+$74,567 QoQ
Shares Held
35,842
+600.7% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#110
of 263 holders
Holding Since
Dec 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $205,108,253 across 117 Biotechnology names. NVAX ranks #90 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
101,908 | $10,865,430 | |
| 2 | MRNA |
Moderna, Inc.
|
139,861 | $9,794,465 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
107,419 | $8,000,567 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
22,923 | $5,610,862 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
67,374 | $5,342,084 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
573,581 | $4,800,872 | |
| 7 | UPB |
Upstream Bio, Inc.
|
693,555 | $4,799,400 | |
| 8 | NRIX |
Nurix Therapeutics, Inc.
|
192,434 | $4,668,448 |
All Filings in NVAX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $337,631 | 35,842 | Shares | Sole | 2026-07-14 | |
| 2022-06-30 | $263,064 | 5,115 | Shares | Sole | 2022-08-08 | |
| 2021-06-30 | $1,192,545 | 5,617 | Shares | Sole | 2021-08-26 | |
| 2021-03-31 | $392,173 | 2,163 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $232,832 | 2,088 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||